A Systematic Review on Efficacy and Safety of Lenalidomide Based Regimens for Treatment of Newly Diagnosed Amyloidosis

被引:0
|
作者
Ahmad, Muhaddis Ejaz [1 ]
Yousaf, Muhammad Abdullah [1 ]
Malik, Mustafa Nadeem [2 ]
Rafae, Abdul [3 ]
Syed, Tariq Iqtidar Sadiq
Abdullah, Syed Maaz [4 ]
Shah, Zunairah [5 ,6 ]
Qamar, Fazeel [1 ]
Ibrahim, Ahmed [1 ]
Anwer, Faiz [7 ]
机构
[1] Rawalpindi Med Univ, Rawalpindi, Pakistan
[2] Univ Arizona, Internal Med, Tucson, AZ USA
[3] McLaren Flint Michigan State Univ, Internal Med, Flint, MI USA
[4] Cleveland Clin, Taussig Canc Ctr, Taussig Ctr, Dept Hematol,Med Oncol, Cleveland, OH 44106 USA
[5] King Edward Med Univ, Lahore, Pakistan
[6] Louis A Weiss Mem Hosp, Dept Internal Med, Chicago, IL USA
[7] Cleveland Clin, Dept Hematol, Taussig Canc Ctr, Med Oncol, Cleveland, OH 44106 USA
关键词
D O I
10.1182/blood-2019-127236
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
5584
引用
收藏
页数:3
相关论文
共 50 条
  • [31] Continuous Lenalidomide Treatment for Newly Diagnosed Multiple Myeloma
    Palumbo, Antonio
    Hajek, Roman
    Delforge, Michel
    Kropff, Martin
    Petrucci, Maria Teresa
    Catalano, John
    Gisslinger, Heinz
    Wiktor-Jedrzejczak, Wieslaw
    Zodelava, Mamia
    Weisel, Katja
    Cascavilla, Nicola
    Iosava, Genadi
    Cavo, Michele
    Kloczko, Janusz
    Blade, Joan
    Beksac, Meral
    Spicka, Ivan
    Plesner, Torben
    Radke, Joergen
    Langer, Christian
    Ben Yehuda, Dina
    Corso, Alessandro
    Herbein, Lindsay
    Yu, Zhinuan
    Mei, Jay
    Jacques, Christian
    Dimopoulos, Meletios A.
    NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (19): : 1759 - 1769
  • [32] COST EFFECTIVENESS OF CHEMOTHERAPY REGIMENS IN PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA: A SYSTEMATIC REVIEW
    Dhanasiri, S.
    Heron, L.
    Medic, G.
    Goodall, M.
    HAEMATOLOGICA, 2012, 97 : 442 - 443
  • [33] Bortezomib-Containing Regimens for the Treatment of Newly Diagnosed AL Amyloidosis: Experience of Two Centers in Canada
    Alahwal, Hatem
    Song, Kevin W.
    Duggan, Peter
    Sutherland, Heather J.
    Neri, Paola
    Broady, Raewyn
    Bahlis, Nizar J.
    Jimenez-Zepeda, Victor
    BLOOD, 2016, 128 (22)
  • [34] Triplet vs doublet lenalidomide-containing regimens for the treatment of elderly patients with newly diagnosed multiple myeloma
    Magarotto, Valeria
    Bringhen, Sara
    Offidani, Massimo
    Benevolo, Giulia
    Patriarca, Francesca
    Mina, Roberto
    Falcone, Antonietta Pia
    De Paoli, Lorenzo
    Pietrantuono, Giuseppe
    Gentili, Silvia
    Musolino, Caterina
    Giuliani, Nicola
    Bernardini, Annalisa
    Conticello, Concetta
    Pulini, Stefano
    Ciccone, Giovannino
    Maisnar, Vladimir
    Ruggeri, Marina
    Zambello, Renato
    Guglielmelli, Tommasina
    Ledda, Antonio
    Liberati, Anna Marina
    Montefusco, Vittorio
    Hajek, Roman
    Boccadoro, Mario
    Palumbo, Antonio
    BLOOD, 2016, 127 (09) : 1102 - 1108
  • [35] Evaluating the Efficacy and Safety of Limiting Dexamethasone in Newly Diagnosed AL Amyloidosis Compared to Conventional Dosing
    Hanna, John
    Brown, Ryan
    Burney, Zain Ali
    Abdallah, Kawther
    Mazzoni, Sandra
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S208 - S208
  • [36] Safety and Efficacy of FLAG-Ida Combined with Venetoclax Treatment for Newly Diagnosed and Relapsed / Refractory AML Patients- a Systematic Review
    Sherban, Adi
    Fredman, Danielle
    Shimony, Shai
    Yeshurun, Moshe
    Raanani, Pia
    Stahl, Maximilian F.
    Gafter-Gvili, Anat
    Wolach, Ofir
    BLOOD, 2022, 140 : 11716 - 11717
  • [37] COMPARATIVE EFFICACY AND SAFETY OF TREATMENT REGIMENS FOR ADVANCED, RECURRENT, OR METASTATIC ENDOMETRIAL CANCER: A SYSTEMATIC REVIEW
    Yeddala, S.
    Yadav, N.
    Prabhune, K.
    Doucette, J.
    Harris, C.
    Murimi-Worstell, I. B.
    VALUE IN HEALTH, 2022, 25 (01) : S24 - S24
  • [38] Efficacy and safety of rifabutin in the treatment of patients with newly diagnosed pulmonary tuberculosis
    McGregor, MM
    Olliaro, P
    Wolmarans, L
    Mabuza, B
    Bredell, M
    Felten, MK
    Fourie, PB
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1996, 154 (05) : 1462 - 1467
  • [39] Comparative efficacy of carfilzomib, lenalidomide, and dexamethasone (KRd) versus bortezomib, lenalidomide, and dexamethasone (VRd) in newly-diagnosed multiple myeloma: A systematic review and meta-analysis
    Costa, Bruno Almeida
    Costa, Thomaz Alexandre
    Pak, Kevin
    Patel, Aesha
    Felix, Nicole
    Mouhieddine, Tarek H.
    Richter, Joshua
    AMERICAN JOURNAL OF HEMATOLOGY, 2024, 99 (07) : 1411 - 1414
  • [40] Systematic Review of the Efficacy and Safety of Alternative Azacitidine Regimens in Myelodysplastic Syndrome
    Shapiro, Roman
    Iansavichene, Alla
    Lazo-Langner, Alejandro
    BLOOD, 2015, 126 (23)